Wealthcare Advisory Partners LLC Makes New $255,000 Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Wealthcare Advisory Partners LLC acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 2,807 shares of the company’s stock, valued at approximately $255,000.

A number of other hedge funds have also recently added to or reduced their stakes in GEHC. Fortitude Family Office LLC bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $29,000. Turtle Creek Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $30,000. Sachetta LLC bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $31,000. Rise Advisors LLC increased its stake in shares of GE HealthCare Technologies by 241.4% in the 1st quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after purchasing an additional 239 shares during the last quarter. Finally, Riverview Trust Co bought a new position in shares of GE HealthCare Technologies in the 1st quarter valued at $31,000. Institutional investors own 82.06% of the company’s stock.

Insider Activity

In other news, CEO Jan Makela sold 20,227 shares of the business’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $81.57, for a total value of $1,649,916.39. Following the transaction, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at approximately $5,167,296.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the sale, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at approximately $5,296,510. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jan Makela sold 20,227 shares of the business’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39. Following the completion of the sale, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at $5,167,296.36. The disclosure for this sale can be found here. Insiders have sold 90,482 shares of company stock valued at $7,369,137 in the last ninety days. 0.27% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Citigroup lifted their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Mizuho cut their price objective on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a report on Wednesday, May 1st. Evercore ISI raised their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. Argus raised their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Finally, The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective on the stock. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $94.09.

GE HealthCare Technologies Stock Down 2.1 %

Shares of GEHC opened at $76.26 on Tuesday. The company has a market capitalization of $34.81 billion, a PE ratio of 22.30, a PEG ratio of 2.80 and a beta of 1.20. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The stock’s 50-day moving average price is $79.69 and its two-hundred day moving average price is $81.85. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.90. The company had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm’s revenue was down 1.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.85 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.16%. The ex-dividend date of this dividend is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.